enGene updates corporate presentation; no specific financial or clinical details disclosed

enGene Therapeutics Inc.

Filed under Item 7.01; presentation furnished as Exhibit 99.1, not deemed filed.
Presentation dated July 2026; content not provided in filing excerpt.
No new material financial, clinical, or operational data available from this filing.
Tickers: ENGN (common) and ENGNW (warrants) trade on Nasdaq.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.